Loading university
Clayton Neighbors — Dr. Clayton Neighbors' research lab at the University of Houston focuses on improving interventions to reduce alcohol consumption among college students. They are currently evaluating a telehealth version of the Brief Alcohol Screening and Intervention for College Students (BASICS), aiming to make effective alcohol support more accessible for students. By comparing this online approach to traditional in-person sessions, they hope to maintain quality care while reducing barriers to treatment.
Chandra Mohan — Dr. Chandra Mohan's lab at the University of Houston focuses on advancing the diagnosis and treatment of systemic lupus erythematosus (SLE), particularly lupus nephritis (LN). Their research involves identifying and validating biomarkers that can help monitor disease progression and predict treatment response, aiming to improve patient outcomes. Additionally, they employ artificial intelligence and computer vision techniques to enhance histological diagnosis of kidney diseases associated with lupus, addressing the challenges of inter-pathologist variability.
Ming Hu — Dr. Ming Hu's lab at the University of Houston focuses on understanding how buprenorphine, a medication for opioid use disorder, affects dental health. They study why high levels of buprenorphine appear in oral fluids and how this contributes to dental caries. The goal is to find ways to reduce the drug's concentration in the mouth without affecting its overall effectiveness, improving the treatment experience for patients.
Gregory D Cuny — Dr. Gregory Cuny's lab at the University of Houston focuses on creating new treatments for cryptosporidiosis, a disease caused by parasitic protozoa that affects people, especially children and those with weakened immune systems. The lab is working on selective inhibitors that target a specific protein involved in the survival of these parasites. This research aims to improve treatment options for those infected, as current medications are limited and ineffective for certain populations.
Vincent H Tam — Dr. Vincent H Tam's lab focuses on fighting multidrug-resistant bacteria that no longer respond to standard antibiotics. The lab is developing a precision medicine platform that can select effective combinations of antibiotics tailored to individual patients. This research is crucial as it aims to prevent a return to the pre-antibiotic era by finding new ways to use existing drugs more effectively.
Kirill V Larin — Dr. Kirill V. Larin's lab at the University of Houston focuses on developing advanced imaging technologies to study how maternal substance exposure affects fetal brain health and to understand corneal biomechanics for diagnosing eye diseases. They use sophisticated imaging techniques to investigate the microvascular changes in fetal brains due to prenatal alcohol and nicotine exposure, as well as to create non-invasive methods to measure corneal elasticity for clinical application. This research aims to improve health outcomes for at-risk infants and enhance treatment strategies for corneal disorders.
Muna I. Naash — Dr. Muna I. Naash's lab at the University of Houston focuses on understanding how certain genetic mutations lead to retinal diseases that can cause blindness. By using animal models, the lab explores the role of a protein called PRPH2 in the health of photoreceptor cells in the retina, aiming to identify therapeutic strategies that could help those affected by these conditions.
Lorra Garey — Dr. Lorra Garey's research focuses on helping Black adults with HIV who smoke cigarettes, addressing their unique challenges related to smoking cessation, mental health, and HIV management. By using a culturally tailored mobile health intervention, her lab aims to reduce barriers to quitting smoking and to improve overall health outcomes. Their innovative approach integrates mental health support into smoking cessation efforts, aiming to provide accessible and effective resources for those who need them most.
Wei-Chuan Shih — Dr. Wei-Chuan Shih's lab at the University of Houston focuses on advancing cancer diagnostics by analyzing circulating tumor exosomes. These tiny vesicles contain important information from cancerous cells, and the lab is developing a novel microfluidic platform to streamline their profiling. This technology aims to improve the detection sensitivity and dynamic range of cancer biomarkers in patient samples without needing invasive blood withdrawal.